Keywords: gsk, buy, cns, inc, million, uk-headquartered, glaxosmithkline

GSK to buy CNS Inc for $566 million

Article | 16 October 2006

Print This

UK-headquartered GlaxoSmithKline, the world's second largest drug company by sales, says that it has entered a definitive agreement for to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in